Home LiteratureArticle Details
PMID: 9765157 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Transition from moderate to excessive drug intake: change in hedonic set point.

Science (New York, N.Y.) ·Vol. 282 ·No. 5387 ·1998-10-09 ·Pages 298-300

Ahmed SH, Koob GF

Abstract

Differential access to cocaine self-administration produced two patterns of drug intake in rats. With 1 hour of access per session, drug intake remained low and stable. In contrast, with 6 hours of access, drug intake gradually escalated over days. After escalation, drug consumption was characterized by an increased early drug loading and an upward shift in the cocaine dose-response function, suggesting an increase in hedonic set point. After 1 month of abstinence, escalation of cocaine intake was reinstated to a higher level than before. These findings may provide an animal model for studying the development of excessive drug intake and the basis of addiction.

MeSH Terms
Animals Behavior, Addictive Cocaine/administration & dosage Cocaine-Related Disorders/etiology Dose-Response Relationship, Drug Drug Tolerance Male Rats Rats, Wistar Reinforcement, Psychology Time Factors
Chemicals
Cocaine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ahmed S H
Division of Psychopharmacology, Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. aserge@sage.scripps.edu
Koob G F
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1998-10-09
Pages
298-300
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Grants
NIDA NIH HHS · DA04398 · United States
NIDA NIH HHS · DA08467 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com